New research suggests that the diabetes drug and popular weight loss treatment semaglutide, commonly known as Ozempic and Wegovy, is linked with a lower risk of dementia — possibly adding to the drug's large list of surprising and unintended benefits. The study, published in the journal eClinicalMedicine, involved analyzing the medical records of more than […]